SINAGRA, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 3.312
AS - Asia 1.920
EU - Europa 1.053
SA - Sud America 412
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 52
OC - Oceania 4
Totale 6.825
Nazione #
US - Stati Uniti d'America 3.176
SG - Singapore 677
CN - Cina 485
BR - Brasile 349
IT - Italia 281
HK - Hong Kong 261
DE - Germania 164
VN - Vietnam 135
BD - Bangladesh 124
FI - Finlandia 108
GB - Regno Unito 90
FR - Francia 88
CA - Canada 78
RU - Federazione Russa 77
UA - Ucraina 76
TR - Turchia 64
IN - India 57
IE - Irlanda 37
JP - Giappone 26
MX - Messico 23
PL - Polonia 21
AR - Argentina 17
ZA - Sudafrica 17
ES - Italia 16
IQ - Iraq 16
NL - Olanda 16
SE - Svezia 15
AT - Austria 13
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
MA - Marocco 10
VE - Venezuela 9
EC - Ecuador 8
KE - Kenya 8
LT - Lituania 8
CO - Colombia 7
PK - Pakistan 7
CL - Cile 6
EE - Estonia 6
IL - Israele 6
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
PH - Filippine 5
SC - Seychelles 5
AZ - Azerbaigian 4
BE - Belgio 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
HN - Honduras 4
ID - Indonesia 4
JM - Giamaica 4
SV - El Salvador 4
AM - Armenia 3
CR - Costa Rica 3
EG - Egitto 3
GT - Guatemala 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
GP - Guadalupe 2
GR - Grecia 2
KZ - Kazakistan 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
Totale 6.749
Città #
Ashburn 381
Singapore 336
San Jose 308
Hong Kong 260
Council Bluffs 172
Beijing 151
New York 118
The Dalles 116
Fairfield 111
Los Angeles 99
Dallas 84
Helsinki 78
Woodbridge 66
Seattle 59
Jacksonville 58
Chandler 57
Lauterbourg 56
Istanbul 55
Munich 55
Columbus 52
Ho Chi Minh City 52
North Bergen 46
Houston 45
Wilmington 44
Princeton 40
Santa Clara 40
São Paulo 40
Milan 39
Cambridge 37
Dublin 37
Buffalo 36
Orem 34
Hanoi 31
Phoenix 29
Romola 27
Redondo Beach 26
San Francisco 26
Ann Arbor 25
Montreal 25
Shanghai 25
Moscow 23
Chennai 21
Tokyo 21
Brooklyn 20
Chicago 20
Rome 20
Washington 20
Brescia 19
London 19
Atlanta 18
Turku 18
Warsaw 18
Frankfurt am Main 17
Boston 16
Nanjing 16
Toronto 16
Guangzhou 14
Nuremberg 14
Brasília 12
Denver 12
Poplar 12
Des Moines 11
Naples 11
City of London 10
Dearborn 10
Hangzhou 10
Johannesburg 10
Lappeenranta 10
Stockholm 10
Belo Horizonte 9
Brno 9
Rio de Janeiro 9
Dhaka 8
Haiphong 8
Hebei 8
San Diego 8
Vienna 8
Amsterdam 7
Boydton 7
Düsseldorf 7
Philadelphia 7
Salvador 7
Ankara 6
Curitiba 6
Da Nang 6
Las Vegas 6
Mumbai 6
Nairobi 6
Newark 6
Novara 6
Paris 6
Portsmouth 6
Querétaro 6
Baghdad 5
Charlotte 5
Hải Dương 5
Jinan 5
Lahore 5
Manchester 5
Mexico City 5
Totale 4.027
Nome #
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 166
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 160
Heart failure and anemia: Effects on prognostic variables 159
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 152
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 151
The chronic heart failure evolutions: Different fates and routes 145
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 143
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 138
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 134
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 130
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 128
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 126
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 125
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 124
The prognostic value of serial troponin measurements in patients admitted for COVID-19 122
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 120
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 119
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 118
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 115
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 114
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 113
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 113
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 111
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 110
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 109
[Palliative inotrope therapy in advanced heart failure: organization and management] 108
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 106
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 104
Impact of malnutrition in patients with severe heart failure 104
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 102
[Transcatheter devices for chronic heart failure: state of the art] 101
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 99
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 99
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 97
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 97
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 95
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 93
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 93
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 93
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 92
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 91
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 91
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 90
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 89
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 88
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 88
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 87
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 84
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 84
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 83
Management of hypertrophic cardiomyopathy 82
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 78
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 74
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 74
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 72
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 72
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 72
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 72
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 71
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 70
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 70
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 69
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 67
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 59
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 58
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 55
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 54
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 53
Totale 6.825
Categoria #
all - tutte 40.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 0 1 5 1 9 7 16 19 40
2022/2023238 37 23 4 4 11 52 2 23 51 3 14 14
2023/2024637 35 13 68 60 43 111 39 23 111 25 26 83
2024/20251.317 15 12 43 144 97 100 173 69 120 91 248 205
2025/20262.919 270 387 205 390 341 213 337 127 195 195 182 77
2026/2027975 158 101 222 463 31 0 0 0 0 0 0 0
Totale 6.825